Detalhe da pesquisa
1.
High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis.
BMC Infect Dis
; 13: 331, 2013 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23870715
2.
Co-infection of Leishmania infantum and a Crithidia-related species in a case of refractory relapsed visceral leishmaniasis with non-ulcerated cutaneous manifestation in Brazil.
Int J Infect Dis
; 133: 85-88, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182549
3.
Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and in vitro experiments.
Front Cell Infect Microbiol
; 12: 1045668, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36506010
4.
Association between Hypertriglyceridemia and Disease Severity in Visceral Leishmaniasis.
Am J Trop Med Hyg
; 106(2): 643-647, 2021 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34814103
5.
Association of IL-9, IL-10, and IL-17 Cytokines With Hepatic Fibrosis in Human Schistosoma mansoni Infection.
Front Immunol
; 12: 779534, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34970264
6.
Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis.
Front Immunol
; 8: 227, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28321221
7.
Soluble CD40 Ligand in Sera of Subjects Exposed to Leishmania infantum Infection Reduces the Parasite Load in Macrophages.
PLoS One
; 10(10): e0141265, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26488744